A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Deucravacitinib Impurity 47 - Request Quote

Picture of Deucravacitinib Impurity 47

Deucravacitinib Impurity 47

SZ CAT No:SZ-D143D20
CAS No
NA
Mol.F.
C10H8D3ClN4O2
Mol.Wt.
257.7
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Deucravacitinib Impurity 47 is chemically 6-Chloro-4-(cyclopropanecarboxamido)-N-(methyl-d3)pyridazine-3-carboxamide. Deucravacitinib Impurity 47 is supplied with detailed characterization data compliant with regulatory guideline. Deucravacitinib Impurity 47 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Deucravacitinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Deucravacitinib Impurity 47

Purchase Deucravacitinib Impurity 47

Deucravacitinib Impurity 47 suppliers

Deucravacitinib Impurity 47 manufacturers

Deucravacitinib Impurity 47 price

Order Deucravacitinib Impurity 47

Enquire Deucravacitinib Impurity 47

Deucravacitinib Impurity 47 cost

Deucravacitinib Impurity 47 Supplier

Deucravacitinib Impurity 47 Distributor

Deucravacitinib Impurity 47 for Method Validation

Deucravacitinib Reference Standard

Deucravacitinib Impurity 47 for ANDA Filing

Deucravacitinib Impurity 47 for Forced Degradation Studies

Deucravacitinib Impurity 47 Identification Standards

Deucravacitinib Impurity 47 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,